Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StopRA: Hydroxychloroquine for RA Prevention
NCT02603146Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2016
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in rheumatoid arthritis (RA), sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2016; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02603146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603146.